The Marshall Protocol Study Site Home

Search
   
Members

Calendar

Help

Home
Search by username
   Not logged in - Login | Register 


FDA investigating the safety of Benicar
 Moderated by: Prof Trevor Marshall Page:  First Page Previous Page  ...  9  10  11  12  13  14   
 

New Topic

Reply

Print
AuthorPost
Bane
Research Team


Joined: Sat Jan 26th, 2008
Location: Norway
Posts: 973
Status:  Offline
 Posted: Tue Dec 8th, 2015 22:41

Quote

Reply
Angiotensin receptor blockers use and the risk of lung cancer: A meta-analysis

http://jra.sagepub.com/content/early/2015/10/03/1470320315607391.long

"This meta-analysis indicated that ARBs may be associated with decreased risk of LC"

Bane
Research Team


Joined: Sat Jan 26th, 2008
Location: Norway
Posts: 973
Status:  Offline
 Posted: Sun Dec 27th, 2015 20:56

Quote

Reply
Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study

http://www.dldjournalonline.com/article/S1590-8658(15)30042-6/abstract

"Incidence of severe olmesartan-associated enteropathy was low. Autoimmune phenomena were present in a subset of cases and reversed after olmesartan removal"

Prof Trevor Marshall
Foundation Staff


Joined: Fri Jul 9th, 2004
Location: Thousand Oaks, California USA
Posts: 15485
Status:  Offline
 Posted: Sun Dec 27th, 2015 23:02

Quote

Reply
Today's researchers are absolutely clueless, and unable to even Google for ideas...

http://lmgtfy.com/?q=autoimmune+olmesartan

..Trevor..

Sallie Q
Support Team


Joined: Sun Jan 25th, 2009
Location: Country_town NSW, Australia
Posts: 5137
Status:  Offline
 Posted: Mon Dec 28th, 2015 03:48

Quote

Reply
not knowing who this is
Olmesartan and Recovery from Autoimmune Disease ... but I really like the sunnies :cool:



____________________
VideoMPsep'08(ptBrk'11 OLM=3x20mg)Dx Depressn'70,node,brCancer'90,BCC ?Bowen05,Sjogren08|SxCFS,RA,stroke,ASD,reflux 25D=9ng/ml_Nov'17AvoidImmuneSuppression
Bane
Research Team


Joined: Sat Jan 26th, 2008
Location: Norway
Posts: 973
Status:  Offline
 Posted: Fri Jul 8th, 2016 01:48

Quote

Reply
The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis.

http://www.ncbi.nlm.nih.gov/pubmed/27158979

"This meta-analysis provides evidence that the use of ACEIs or ARBs in cancer patients can lead to a 40 and 25% reduction in the risk of cancer recurrence and mortality"

scooker48
Member*


Joined: Mon Jan 3rd, 2005
Location: Sunnyvale, California USA
Posts: 1690
Status:  Offline
 Posted: Fri Jul 8th, 2016 02:04

Quote

Reply
Good news:).

Sherry



____________________
D25, Total: 12 measured 11/3/15 Started MP=01/04/05 Diagnosis: Sarc 12/04; "cat scratch disease" or necrotizing graunulomas 10/88; Raynaud's (diagnosed 1980?)
Bane
Research Team


Joined: Sat Jan 26th, 2008
Location: Norway
Posts: 973
Status:  Offline
 Posted: Fri Jul 8th, 2016 02:08

Quote

Reply
scooker48 wrote:
Good news:).

Sherry


yes:)

Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872747/

Overall, this study indicates that use of RAS inhibitors may be associated with a decreased risk of prostate cancer. Large-scale well designed studies are needed to further explore this association.


Angiotensin receptor blockers (ARBs) reduce the risk of lung cancer: a systematic review and meta-analysis

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612864/

In conclusion, our meta-analysis demonstrated that ARBs was significantly associated with lower lung cancer.

Nyima
Support Team


Joined: Wed Apr 27th, 2011
Location: United Kingdom
Posts: 2601
Status:  Offline
 Posted: Fri Jul 8th, 2016 16:24

Quote

Reply
Great find:).  And I'm assuming these benefits were noted at 'normal' doses, so researchers are only viewing the very fringe of what is possible with ARBs.



____________________
MP start Dec 10 (2 mo. break Jan-Mar '11) | Multinodular thyroid | frequent illness| fatigue | brain-fog | gluten intolerance (poss coeliac), eczema with dairy products | 25D (ng/ml): 4(14 Apr 11), 5.3(26 Apr 13), 4(Jan 14), 5.5(July 14)
Bane
Research Team


Joined: Sat Jan 26th, 2008
Location: Norway
Posts: 973
Status:  Offline
 Posted: Thu Dec 1st, 2016 04:24

Quote

Reply
Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction.

https://www.ncbi.nlm.nih.gov/pubmed/27865680

CONCLUSIONS:
In this observational study of patients with NSTEMI, all of them treated successfully by PCI, the use of ACEIs/ARBs was significantly associated with a lower risk of four-year all-cause mortality.


 Current time is 11:40
Page:  First Page Previous Page  ...  9  10  11  12  13  14   



* We can help you understand chronic disease, but only your physician is licensed to give you medical care *

Powered by WowBB 1.7 - Entire site Copyright © 2004-2018 Autoimmunity Research Foundation, All Rights Reserved
Click here to view our PRIVACY POLICY
Page processed in 0.0908 seconds (49% database + 51% PHP). 17 queries executed.